[go: up one dir, main page]

IS7660A - Nýjar bensóímídasólafleiður nytsamlegar sem andviðkomumiðlar - Google Patents

Nýjar bensóímídasólafleiður nytsamlegar sem andviðkomumiðlar

Info

Publication number
IS7660A
IS7660A IS7660A IS7660A IS7660A IS 7660 A IS7660 A IS 7660A IS 7660 A IS7660 A IS 7660A IS 7660 A IS7660 A IS 7660A IS 7660 A IS7660 A IS 7660A
Authority
IS
Iceland
Prior art keywords
antidepressants
useful
new
benzoimidazole derivatives
benzoimidazole
Prior art date
Application number
IS7660A
Other languages
English (en)
Other versions
IS2738B (is
Inventor
Charles Kath John
Peter Lyssikatos Joseph
Fay Wang Huifen
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS7660A publication Critical patent/IS7660A/is
Publication of IS2738B publication Critical patent/IS2738B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS7660A 2002-08-28 2005-01-20 Tæki til þess að hreinsa bræddan málm IS2738B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40652402P 2002-08-28 2002-08-28
US41704702P 2002-10-08 2002-10-08
PCT/IB2003/003634 WO2004020431A2 (en) 2002-08-28 2003-08-14 Novel benzoimidazole derivatives useful as antiproliferative agents

Publications (2)

Publication Number Publication Date
IS7660A true IS7660A (is) 2005-01-20
IS2738B IS2738B (is) 2011-06-15

Family

ID=31981411

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7660A IS2738B (is) 2002-08-28 2005-01-20 Tæki til þess að hreinsa bræddan málm

Country Status (40)

Country Link
US (1) US7071337B2 (is)
EP (1) EP1594858B1 (is)
JP (1) JP4551771B2 (is)
KR (2) KR20070086768A (is)
CN (1) CN1319966C (is)
AP (1) AP2005003237A0 (is)
AR (1) AR041055A1 (is)
AT (1) ATE445610T1 (is)
AU (1) AU2003250499B2 (is)
BR (1) BRPI0313942C1 (is)
CA (1) CA2495577C (is)
CR (1) CR7698A (is)
CU (1) CU23413B7 (is)
CY (1) CY1110580T1 (is)
DE (1) DE60329715D1 (is)
DK (1) DK1594858T3 (is)
DO (1) DOP2003000694A (is)
EA (1) EA008448B1 (is)
EC (1) ECSP055633A (is)
ES (1) ES2333219T3 (is)
GE (1) GEP20064005B (is)
HN (1) HN2003000257A (is)
HR (1) HRP20050191B1 (is)
IL (1) IL166832A (is)
IS (1) IS2738B (is)
MA (1) MA27389A1 (is)
MX (1) MXPA05001256A (is)
MY (1) MY139357A (is)
NO (1) NO20051303L (is)
NZ (1) NZ538427A (is)
OA (1) OA12916A (is)
PA (1) PA8580301A1 (is)
PE (1) PE20050131A1 (is)
PL (1) PL377678A1 (is)
PT (1) PT1594858E (is)
RS (1) RS20050180A (is)
SI (1) SI1594858T1 (is)
TW (1) TW200407131A (is)
UY (1) UY27952A1 (is)
WO (1) WO2004020431A2 (is)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100404530C (zh) * 2003-06-24 2008-07-23 辉瑞产品公司 1-[2-(苯并咪唑-1-基)喹啉-8-基]哌啶-4-基胺衍生物的制备方法
WO2005094830A1 (en) * 2004-03-30 2005-10-13 Pfizer Products Inc. Combinations of signal transduction inhibitors
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds
JP2008515872A (ja) * 2004-10-07 2008-05-15 ファイザー・プロダクツ・インク 抗増殖剤として有用なベンゾイミダゾール誘導体
GEP20115226B (en) 2005-04-26 2011-06-10 Pfizer P-cadherin antibodies
SI1933871T1 (sl) 2005-09-07 2013-10-30 Amgen Fremont Inc. Humana monoklonska protitelesa proti aktivin receptorju podobni kinazi-1
EP2021338A1 (en) 2006-05-09 2009-02-11 Pfizer Products Inc. Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
KR101538179B1 (ko) 2007-04-03 2015-07-20 어레이 바이오파마 인크. 수용체 티로신 키나제 억제제로서의 이미다조[1,2-a]피리딘 화합물
JP6022158B2 (ja) 2008-05-21 2016-11-09 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation 2−フルオロ−N−メチル−4−[7−(キノリン−6−イル−メチル)−イミダゾ[1,2−b][1,2,4]トリアジン−2−イル]ベンズアミドの塩及びそれを調製することに関する方法
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
AU2011297961B2 (en) 2010-09-02 2015-07-02 Merck Patent Gmbh Pyrazolopyridinone derivatives as LPA receptor antagonists
GB201103578D0 (en) 2011-03-02 2011-04-13 Sabrepharm Ltd Dipyridinium derivatives
KR101738063B1 (ko) * 2012-09-21 2017-05-19 아로그 파마슈티칼스, 인코퍼레이티드 구조적으로 활성인 인산화된 flt3 키나제의 억제 방법
US10835525B2 (en) 2012-09-26 2020-11-17 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
KR20140040594A (ko) * 2012-09-26 2014-04-03 아로그 파마슈티칼스, 엘엘씨 돌연변이체 c-kit의 억제 방법
US11642340B2 (en) 2012-09-26 2023-05-09 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
BR112015016282A2 (en) 2013-01-07 2017-07-11 Arog Pharmaceuticals, Inc. crenolanib for treatment of mutated flt3 proliferative disorders
US10463658B2 (en) 2013-10-25 2019-11-05 Videra Pharmaceuticals, Llc Method of inhibiting FLT3 kinase
LT3212629T (lt) * 2014-10-31 2019-01-10 Genoscience Pharma Sas Pakeistieji 2,4 diamino-chinolinai, kaip nauji priešvėžiniai agentai
GB2543550A (en) 2015-10-21 2017-04-26 Hox Therapeutics Ltd Peptides
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US10577362B2 (en) 2016-05-04 2020-03-03 Genoscience Pharma Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases
SG11201903889TA (en) 2016-11-02 2019-05-30 Arog Pharmaceuticals Inc Crenolanib for treating flt3 mutated proliferative disorders associated mutations
CN107382984B (zh) * 2017-08-24 2020-07-10 扬州市三药制药有限公司 一种治疗白血病药物的制备方法
CN107382983B (zh) * 2017-08-24 2020-08-07 扬州市三药制药有限公司 一种治疗白血病药物的合成方法
CN110840893A (zh) 2018-12-13 2020-02-28 安罗格制药有限责任公司 含克莱拉尼的药物组合物及其用途
US11471451B2 (en) 2019-08-19 2022-10-18 Arog Pharmaceuticals, Inc. Uses of crenolanib
CN114702428B (zh) * 2019-12-09 2023-11-28 苏州恩华生物医药科技有限公司 连双环结构sigma-1受体抑制剂
JP7769388B2 (ja) 2019-12-12 2025-11-13 ティン セラピューティクス,インコーポレイテッド 聴覚損失の予防及び治療のための組成物及び方法
EP4181923A4 (en) * 2020-07-20 2024-08-07 Arog Pharmaceuticals, Inc. Crystal forms of crenolanib and methods of use thereof
US11713310B2 (en) 2020-07-20 2023-08-01 Arog Pharmaceuticals, Inc. Crystal forms of crenolanib and methods of use thereof
EP4192459A4 (en) * 2020-08-05 2024-12-04 The General Hospital Corporation SALT-INDUCABLE KINASE INHIBITORS
US11524006B2 (en) 2020-09-17 2022-12-13 Arog Pharmaceuticals, Inc. Crenolanib for treating TRK kinase associated proliferative disorders
US11969420B2 (en) 2020-10-30 2024-04-30 Arog Pharmaceuticals, Inc. Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders
WO2022090547A1 (en) 2020-10-30 2022-05-05 Dsm Ip Assets B.V. Production of carotenoids by fermentation
CN113683594B (zh) * 2021-09-07 2022-12-27 曲靖师范学院 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用
JP2023063189A (ja) 2021-10-22 2023-05-09 アログ・ファーマシューティカルズ・インコーポレイテッド 以前の治療に対して再発性/不応性のflt3突然変異増殖性障害を治療するためのクレノラニブ
CA3237696A1 (en) 2021-11-08 2023-05-11 Progentos Therapeutics, Inc. Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
CN114409632B (zh) * 2022-02-22 2024-04-30 北京鲲达宇科技有限公司 2-取代氨基-3-苯并咪唑取代的喹啉衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US5990146A (en) 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
WO1999016755A1 (en) 1997-09-26 1999-04-08 Merck & Co., Inc. Novel angiogenesis inhibitors
EP1233956A4 (en) * 1999-11-30 2006-07-05 Univ Leland Stanford Junior BRYOSTATIN ANALOGUES, METHODS OF SYNTHESIS AND USES
UA75055C2 (uk) * 1999-11-30 2006-03-15 Пфайзер Продактс Інк. Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
JP2008002005A (ja) * 2006-06-21 2008-01-10 Shimada Shoji Kk 衣服用パッド

Also Published As

Publication number Publication date
CA2495577C (en) 2010-06-15
HRP20050191A2 (en) 2005-10-31
CR7698A (es) 2007-11-23
CN1678604A (zh) 2005-10-05
IL166832A (en) 2011-03-31
AU2003250499A1 (en) 2004-03-19
EA008448B1 (ru) 2007-06-29
HRP20050191B1 (hr) 2013-12-20
DK1594858T3 (da) 2009-12-14
MY139357A (en) 2009-09-30
HN2003000257A (es) 2004-12-01
PT1594858E (pt) 2009-12-14
AU2003250499B2 (en) 2009-04-23
EP1594858A2 (en) 2005-11-16
PL377678A1 (pl) 2006-02-06
BR0313942A (pt) 2005-07-12
SI1594858T1 (sl) 2010-01-29
BRPI0313942B1 (pt) 2019-06-04
DOP2003000694A (es) 2004-02-29
ECSP055633A (es) 2005-04-18
PA8580301A1 (es) 2005-05-24
CU23413B7 (es) 2009-09-08
NO20051303L (no) 2005-05-18
ES2333219T3 (es) 2010-02-18
AR041055A1 (es) 2005-04-27
AP2005003237A0 (en) 2005-03-31
KR20070086768A (ko) 2007-08-27
OA12916A (en) 2006-10-13
WO2004020431A2 (en) 2004-03-11
MXPA05001256A (es) 2005-06-08
BRPI0313942B8 (pt) 2020-08-04
NZ538427A (en) 2007-04-27
PE20050131A1 (es) 2005-03-21
KR100816166B1 (ko) 2008-03-21
JP2006501309A (ja) 2006-01-12
JP4551771B2 (ja) 2010-09-29
CY1110580T1 (el) 2015-04-29
HRP20050191A9 (hr) 2013-11-22
EP1594858B1 (en) 2009-10-14
US20050124599A1 (en) 2005-06-09
UY27952A1 (es) 2004-03-31
RS20050180A (sr) 2007-08-03
MA27389A1 (fr) 2005-06-01
ATE445610T1 (de) 2009-10-15
CA2495577A1 (en) 2004-03-11
WO2004020431A3 (en) 2004-05-13
EA200500174A1 (ru) 2005-08-25
DE60329715D1 (de) 2009-11-26
BRPI0313942C1 (pt) 2021-05-25
US7071337B2 (en) 2006-07-04
IS2738B (is) 2011-06-15
KR20050036984A (ko) 2005-04-20
HK1078571A1 (en) 2006-03-17
CN1319966C (zh) 2007-06-06
GEP20064005B (en) 2006-12-25
TW200407131A (en) 2004-05-16

Similar Documents

Publication Publication Date Title
IS7660A (is) Nýjar bensóímídasólafleiður nytsamlegar sem andviðkomumiðlar
IS7667A (is) Nýjar bensimídazólafleiður
DE60304683D1 (de) Auftrennwerkzeug
ITMI20020148A0 (it) Nuovi corticosteroidi
DK1492934T3 (da) Dørenhed
NO20044140D0 (no) New Composition
SE0202927D0 (sv) Spridare
ITMI20021327A1 (it) Nuove ossialchilpiperazine
DE502004007109D1 (de) Turbomaschine
UA6456S (uk) Шпалери
UA6464S (uk) Шпалери
UA6025S (uk) Шпалери
UA6026S (uk) Шпалери
UA6457S (uk) Шпалери
UA6450S (uk) Шпалери
UA6451S (uk) Шпалери
UA6452S (uk) Шпалери
UA6453S (uk) Шпалери
UA6017S (uk) Шпалери
UA6019S (uk) Шпалери
UA6455S (uk) Шпалери
UA6449S (uk) Шпалери
UA6022S (uk) Шпалери
UA6459S (uk) Шпалери
UA6460S (uk) Шпалери